Skip to main content
Log in

Insulin releasing effects of mastoparan and amphiphilic substance P receptor antagonists on RINm5F insulinoma cells

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

It has been proposed that mastoparan (INLKALAALAKKIL) and other mast cell secretagogues such as substance P (SP) or compound 48/80 act by direct activation of the pertussis toxin (PTX)-sensitive G-proteins in intact cells. Here we have investigated whether or not the antagonists of SP, [D-Trp7, 9, 10] SP1-11 and [D-Trp7, 9, 10, N-leu11] SP1-11, can similarly induce exocytosis from RINm5F cells. In intact cells mastoparan and the SP antagonists stimulated insulin release in a dose-dependent manner at concentrations ranging from 10 to 100 µM. The maximal effect on insulin release, of both mastoparan and the SP antagonists was comparable to that obtained with 100 µM forskolin. Pretreatment of the intact cells, for 18 h with PTX or 6 h with cholera toxin, did not change the responses induced by both mastoparan and the SP antagonists. This absence of PTX effect, despite the fact that the three PTX substrates at 41, 40 and 39 kDa were ADP ribosylated after pretreatment suggests intrinsic differences between mast and RINm5F cells. Thus the SP antagonists behave similarly to mastoparan in its ability to induce insulin release in RINm5F cells. However, the higher concentrations required with RINm5F cells compared to that needed for mast cells suggest differences either in G-proteins composition or in the phospholipid composition of the membranes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

SP-Substance P:

SPa:[d-Trp7, 9, 10] SP1−11, SPb:[D-Trp7, 9, 10, N-leu11]SP1−11

References

  1. Hirai Y, Yasuhara T, Yoshida H, Nakajima T: A new mast cell degranulating peptide ‘mastoparan’ in the venom of Vespula lewisii. In: S Shiba (ed.) Peptide Chemistry. Osaka, Protein Research Foundation, 1978, pp 155–160

    Google Scholar 

  2. Higashijima T, Wakamatsu K, Takemirsu M, Fujino M, Nakajima T, Miyazawa T: Conformational change of mastoparan from wasp venom on binding with phospholipid membrane. FEBS Lett 152: 228–230, 1983

    Google Scholar 

  3. Wakamatsu K, Higashijima T, Fujino M, Nakajima T, Miyazawa T: Transferred NOE analyses of conformations of peptides as bound to membrane bilayer of phospholipid; mastoparan-X. FEBS Lett 162: 123–125, 1983

    Google Scholar 

  4. Higashijima T, Uzu S, Nakajima T, Ross EM: Mastoparan, a peptide toxin from Wasp Venom, mimics receptors by activating GTP-binding Regulatory Proteins (G Proteins). J Biol Chem 263: 6491–6494, 1988

    Google Scholar 

  5. Strader CD, Sigal IS, Dixon RAF: Structural basis of β-adre-nergic receptor function. FASEB J 3: 1825–1832, 1989

    Google Scholar 

  6. Cheung AH, Sigal IS, Dixon RAF, Strader CD: Agonist-promoted sequestration of the β2-adrenergic receptor requires regions involved in functional coupling with Gs. Mol Pharmacol 34: 132–138, 1989

    Google Scholar 

  7. Mousli M, Bronner C, Bueb JL, Tschirhart E, Gies JP, Landry Y: Activation of rat peritoneal Mast Cells by Substance P and Mastoparan. J Pharmacol Exp Ther 250: 329–335, 1989

    Google Scholar 

  8. Argiolas A, Pisano JJ: Facilitation of phospholipase A, activity by mastoparans, a new class of mast cell degranulating peptides from wasp venom. J Biol Chem 258: 13697–13702, 1983

    Google Scholar 

  9. Hirai Y, Kuwada T, Yoshida H, Nakajima T: A new mast cell degranulating peptide homologous to mastoparan in the venom of Japanese hornet (Vespa xanthoptera). Chem Pharm Bull 27: 1945–1946, 1979

    Google Scholar 

  10. Kuroda Y, Yoshioka M, Kumakura K, Kobayashi K, Nakajima T: Effects of peptides on the release of catecholamines and adenine nucleotides from cultured adrenal chromaffin cells. Proc Japan Acad 56: 660–664, 1980

    Google Scholar 

  11. Kurihara H, Kitajima K, Senda T, Fujita H, Nakajima T: Multigranular exocytosis induced phospholipase A,-activators, melittin and mastoparan, in rat antrerior pituitary cells. Cell Tissue Res 243: 311–316, 1986

    Google Scholar 

  12. Burgoyne RD: Control of exocytosis. Nature 328: 112–113, 1987

    Google Scholar 

  13. Korman LY, Bhathena SJ, Voyles NR, Oie HK, Recant L: Characteristics of the interaction of the glucagon receptor, cAMP and insulin secretion in parent cells and clone 5F of a cultured rat insulinoma. Diabetes 34: 717–722, 1985

    Google Scholar 

  14. Amiranoff B, Lorinet AM, Lagny-Pourmir I, Laburthe M: Mechanism of galanin-inhibited insulin release. Eur J Biochem 177: 147–152, 1988

    Google Scholar 

  15. Lambert DG, Atkins TW: Nutrient induced insulin release from an insulinoma derived β-cell line. Acta Diabetol Lat 24: 299–304, 1987

    Google Scholar 

  16. Herbert V, Law KS, Gottlieb CW, Bleicher SJ: Coated charcoal immunoassay of insulin. J Clin Endocr 25: 1375–1384, 1965

    Google Scholar 

  17. Toutant M, Aunis D, Bockaert J, Homburger V, Rouot B: Presence of three pertussis toxin substrates and Go immunoreactivity in bot plasma and granule membranes of chromaffin cells. FEBS Lett 215: 339–344, 1987

    Google Scholar 

  18. Zar, JH: Biostatistical analysis. Englewood cliffs. N.J. Prentice Hall, 1974, pp 151–181

    Google Scholar 

  19. Henquin JC, Lambert A: Cobalt inhibition of insulin secretion and calcium uptake by isolated rat islets. Am J Physiol 228: 1669–1677, 1975

    Google Scholar 

  20. Henquin JC, Meissner HP: The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic β-cells: studies with forskolin. Endocrinology 115: 1125–1134, 1984

    Google Scholar 

  21. Nakako Y, Mitsuhisa K, Teiji T, Toru A, Takashi Y: Mastoparan, a wasp venom, stimulates insulin release by pancreatic islets through pertussis toxin sensitive GTP-binding protein. Biochem Biophys Res Commun 158: 712–716, 1989

    Google Scholar 

  22. Vallar L, Biden J, Wollheim CB: Guanine necleotide induce Ca2−-independent insulin secretion from permeabilized Rin m 5F cells. J Biol Chem 262: 5049–5056, 1987

    Google Scholar 

  23. Wollheim CB, Ullrich S, Meda P, Vallar L: Regulation of exocytosis in electrically permeabilized insulin-secreting cells. Evidence for Ca2+ dependent and independent secretion. Bioscience Reports 7: 443–453, 1987

    Google Scholar 

  24. Chiba Y, Kawai K, Okuda Y, Munekata E, Yamashita K: Effects of substance P and substance P-(6–11) on hormone release from isolated perfused pancreas: their opposite actions on rat and canine islets. Endocrinology 117: 1996–2000, 1985

    Google Scholar 

  25. Mousli M, Bueb JL, Bronner C, Rouot B, Landry Y: G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci 11: 358–362, 1990

    Google Scholar 

  26. Perianin A, Snyderman R: Mastoparan, a wasp venom peptide, identifies two discrete mechanisms for elevating cytosolic calcium and inositol triphosphates in human polymorphonuclear leukocytes. J Immunol 143: 1669–1673, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hillaire-Buys, D., Mousli, M., Landry, Y. et al. Insulin releasing effects of mastoparan and amphiphilic substance P receptor antagonists on RINm5F insulinoma cells. Mol Cell Biochem 109, 133–138 (1992). https://doi.org/10.1007/BF00229767

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00229767

Key words

Navigation